A Decade of Experience with Injectable Poly-L-Lactic Acid: A Focus on Safety

CYNTHIA BARTUS, MD, C. WILLIAM HANKE, MD, AND ELIZABETH DARO-KAFTAN, PHD

Important lessons have been learned in the use of injectable PLLA that have helped reduce the frequency of adverse events and make it desirable for restoring facial volume (Table 1). The importance of diffuse distribution of the injectable PLLA suspension

Injection technique in neurotoxins and fillers: Indications, products, and outcomes

Murad Alam, MD, MBA, MSCI, and Rebecca Tung, MD Chicago and Maywood, Illinois

Injectable fillers and neuromodulators are used for a range of indications pertaining to the correction of facial aging and disfigurement. Fillers can correct soft tissue loss, depressed scars, and atrophy or asymmetry induced by systemic or local disease

Efficacy and safety of injection with poly-L-lactic acid compared with hyaluronic acid for correctio

M. Y. Hyun, Y. Lee, Y. A. No, K. H. Yoo, M. N. Kim, C. K. Hong, S. E. Chang, C. H. Won and B. J. Kim

At week 24, mean improvement in WSRS from baseline was 2.09  0.68 for the PLA side and 1.54  0.65 for the HA side. Both injections were well toler- ated, and the adverse reactions were mild and transient in most cases. PLA provides noninferior efficac

Multicenter Prospective Cohort Study of the Incidence of Adverse Events Associated With Cosmetic Der

Murad Alam, MD, MSCI; Rohit Kakar, MD; Michael Nodzenski, BA; Omer Ibrahim, MD; Wareeporn Disphanurat, MD; Diana Bolotin, MD, PhD; Judy H. Borovicka, MD; Natalie Pace, BS; Tina S. Alster, MD; Kenneth A. Arndt, MD; Kenneth R. Beer, MD; Joshua M. Berlin, MD
0.049681s